Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.46 |
| ▸ | RAB9A | P51151 | 3/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | HPGD | P15428 | 2/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | GPR3 | P46089 | 1/20 | 0.45 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.42 |
| ▸ | LIMK1 | P53667 | 2/20 | 0.40 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.40 |
| ▸ | CDK5R1 | Q15078 | 1/20 | 0.40 |
| ▸ | TNKS | O95271 | 1/20 | 0.40 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.39 |
| ▸ | ATM | Q13315 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | IKBKB | O14920 | 1/20 | 0.39 |
| ▸ | HKDC1 | Q2TB90 | 1/20 | 0.39 |
| ▸ | TDO2 | P48775 | 1/20 | 0.38 |
| ▸ | CTSB | P07858 | 1/20 | 0.37 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19607175 | 0.85 | MAPT (0.46) | MAPTRAB9AALDH1A1HPGDSMN1; SMN2 | |
| SCHEMBL19607174 | 0.85 | MAPT (0.42) | MAPTRAB9AALDH1A1HPGDSMN1; SMN2 | |
| SCHEMBL1294718 | 0.79 | GPR3 (0.50) | MAPTRAB9AALDH1A1HPGDSMN1; SMN2 | |
| SCHEMBL30340721 | 0.79 | GPR3 (0.50) | MAPTRAB9AALDH1A1HPGDSMN1; SMN2 | |
| SCHEMBL20441721 | 0.79 | PTPN1 (0.60) | MAPTRAB9AALDH1A1HPGDSMN1; SMN2 | |
| SCHEMBL17987488 | 0.79 | MAPT (0.50) | MAPTRAB9AALDH1A1HPGDSMN1; SMN2 | |
| SCHEMBL22172094 | 0.76 | PTPN1 (0.50) | MAPTRAB9AALDH1A1HPGDSMN1; SMN2 | |
| SCHEMBL5028205 | 0.76 | MAPT (0.47) | MAPTRAB9AALDH1A1HPGDSMN1; SMN2 | |
| SCHEMBL16867080 | 0.76 | PTPN1 (0.47) | MAPTRAB9AALDH1A1HPGDSMN1; SMN2 | |
| SCHEMBL23589564 | 0.76 | ALOX5 (0.55) | MAPTRAB9AALDH1A1HPGDSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2539913-B1 | PHOSPHORESCENT EMITTERS | UNIVERSAL DISPLAY CORP (US) | 2017-09-27 | — | — | EP | disclosed |
| EP-2539913-B1 | PHOSPHORESCENT EMITTERS | UNIVERSAL DISPLAY CORP (US) | 2017-09-27 | — | — | EP | disclosed |
| US-9156870-B2 | Phosphorescent emitters | UNIVERSAL DISPLAY CORPORATION (US) | 2015-10-13 | — | — | US | disclosed |
| US-9156870-B2 | Phosphorescent emitters | UNIVERSAL DISPLAY CORPORATION (US) | 2015-10-13 | — | — | US | disclosed |
| US-9156870-B2 | Phosphorescent emitters | UNIVERSAL DISPLAY CORPORATION (US) | 2015-10-13 | — | — | US | disclosed |
| EP-2539913-A1 | PHOSPHORESCENT EMITTERS | Universal Display Corporation (US) | 2013-01-02 | — | — | EP | disclosed |
| WO-2011106344-A1 | PHOSPHORESCENT EMITTERS | UNIVERSAL DISPLAY CORPORATION (US) | 2011-09-01 | — | — | WO | disclosed |
| WO-2011106344-A1 | PHOSPHORESCENT EMITTERS | UNIVERSAL DISPLAY CORPORATION (US) | 2011-09-01 | — | — | WO | disclosed |
| US-20110204333-A1 | PHOSPHORESCENT EMITTERS | UNIVERSAL DISPLAY CORPORATION (US) | 2011-08-25 | — | — | US | disclosed |
| US-20110204333-A1 | PHOSPHORESCENT EMITTERS | UNIVERSAL DISPLAY CORPORATION (US) | 2011-08-25 | — | — | US | disclosed |
| US-20110204333-A1 | PHOSPHORESCENT EMITTERS | UNIVERSAL DISPLAY CORPORATION (US) | 2011-08-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110204333-A1 | PHOSPHORESCENT EMITTERS | TEC, IK, DDT | MAPT 165/4885RAB9A 724/4885ALDH1A1 2042/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.